You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy

 

Online download statistics by month:

Online download statistics by month: September 2022 to January 2026

AbstractFullPdf
Sep 2022646658203
Oct 2022482486115
Nov 202216516674
Dec 202212412853
Jan 202312612657
Feb 202311211451
Mar 2023868834
Apr 2023788037
May 2023777850
Jun 2023838329
Jul 2023727267
Aug 2023878822
Sep 2023838335
Oct 202312012040
Nov 2023939440
Dec 2023979938
Jan 2024727340
Feb 2024656523
Mar 202410710756
Apr 2024939342
May 202415215367
Jun 202413313260
Jul 2024798034
Aug 2024696718
Sep 2024575732
Oct 2024858648
Nov 202410911135
Dec 2024868732
Jan 2025868637
Feb 2025707035
Mar 2025858649
Apr 202510210555
May 2025828238
Jun 2025606228
Jul 2025110
Sep 2025220
Jan 2026110
Total412741691674